Laura Huppert
Medical oncologist at the University of California, San Francisco, specializing in breast cancer and discussing clinical use and integration of antibody-drug conjugates in metastatic breast cancer.
Best podcasts with Laura Huppert
Ranked by the Snipd community
Oct 14, 2025 • 44min
HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Dr. Laura Huppert, a medical oncologist at UCSF specializing in breast cancer, dives deep into the world of antibody-drug conjugates (ADCs). She explains how ADCs work and discusses their current use in treating HR-positive and triple-negative metastatic breast cancer. Listeners will find insights on managing ADC toxicities, the latest investigational therapies, and considerations for treatment sequencing. Huppert's enthusiasm for integrating innovations in ADCs hints at a promising future for breast cancer management.
May 9, 2024 • 2h 13min
Virtual Case Library: Metastatic Triple-Negative Breast Cancer
Oncology experts discuss research on metastatic triple-negative breast cancer, including a predictive survival tool and treatment approaches like immunotherapy and antibody drug conjugates. They address challenges in diagnosing and managing complications, exploring immune-related adverse events and CNS progression. The synergy of immune checkpoint inhibitors and ADCs, optimizing treatment sequencing, patient experiences with TDXD therapy, and the role of PARP inhibitors are also highlighted.
